Scpharmaceuticals Inc (SCPH) — Financial Flexibility Index
Scpharmaceuticals Inc (SCPH) has a Financial Flexibility Index of -0.16x as of June 2025. Free cash flow of $-16.11 Million (operating CF $-16.11 Million minus capex $0.00) represents 0% of total liabilities ($101.57 Million). Also explore Scpharmaceuticals Inc (SCPH) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Scpharmaceuticals Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Scpharmaceuticals Inc across 10 annual periods. Check Scpharmaceuticals Inc (SCPH) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Scpharmaceuticals Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Scpharmaceuticals Inc. For the full company profile including market capitalisation, see Scpharmaceuticals Inc (SCPH) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.75x | $-70.52 Million | $-70.54 Million | $94.20 Million | ▲ +27.6% |
| 2023 | -1.03x | $-59.20 Million | $-59.24 Million | $57.26 Million | ▼ -54.9% |
| 2022 | -0.67x | $-34.56 Million | $-34.58 Million | $51.76 Million | ▲ +44.5% |
| 2021 | -1.20x | $-27.14 Million | $-27.15 Million | $22.57 Million | ▼ -16.8% |
| 2020 | -1.03x | $-27.68 Million | $-27.69 Million | $26.88 Million | ▲ +12.3% |
| 2019 | -1.17x | $-30.43 Million | $-30.44 Million | $25.92 Million | ▲ +38.8% |
| 2018 | -1.92x | $-28.80 Million | $-28.81 Million | $15.01 Million | ▼ -37.0% |
| 2017 | -1.40x | $-22.49 Million | $-22.68 Million | $16.05 Million | ▼ -597.0% |
| 2016 | -0.20x | $-15.45 Million | $-15.46 Million | $76.85 Million | ▲ +58.0% |
| 2015 | -0.48x | $-9.62 Million | $-9.64 Million | $20.09 Million | — |